1. Havers, FP., Reed, C., Lim, T et al. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020 (published online July 21, 2020). JAMA Intern Med.doi:10.1001/jamainternmed.2020.4130
Google Scholar2. Yousaf, AR., Duca, LM., Chu, V et al. A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time. Clin Infect Dis. 2021;73(7):e1841-e1849.doi:10.1093/cid/ciaa1072 32719874
Google Scholar | Crossref | Medline3. Oran, DP., Topol, EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362-367.doi:10.7326/M20-3012 32491919
Google Scholar | Crossref | Medline4. Clapham, H., Hay, J., Routledge, I et al. Seroepidemiologic study designs for determining SARS-CoV-2 transmission and immunity. Emerg Infect Dis. 2020;26(9):1978-1986.doi:10.3201/eid2609.201840 32544053
Google Scholar | Crossref | Medline5. Shook-Sa, BE., Boyce, RM., Aiello, AE. Estimation without representation: early severe acute respiratory syndrome coronavirus 2 seroprevalence studies and the path forward. J Infect Dis. 2020;222(7):1086-1089.doi:10.1093/infdis/jiaa429 32750135
Google Scholar | Crossref | Medline6. Bajema, KL., Wiegand, RE., Cuffe, K et al. Estimated SARS-CoV-2 seroprevalence in the US as of September 2020. JAMA Intern Med. 2021;181(4):450-460.doi:10.1001/jamainternmed.2020.7976 33231628
Google Scholar | Crossref | Medline7. Boyce, RM., Shook-Sa, BE., Aiello, AE. A tale of two studies: study design and our understanding of SARS-CoV-2 seroprevalence (published online December 18, 2020). Clin Infect Dis.doi:10.1093/cid/ciaa1868
Google Scholar8. Biggs, HM., Harris, JB., Breakwell, L et al. Estimated community seroprevalence of SARS-CoV-2 antibodies—two Georgia counties, April 28–May 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(29):965-970.doi:10.15585/mmwr.mm6929e2 32701941
Google Scholar | Crossref | Medline9. Centers for Disease Control and Prevention . Community Assessment for Public Health Emergency Response (CASPER) Toolkit: Third Edition. Centers for Disease Control and Prevention; 2019.
Google Scholar10. City and County of Denver . Census blocks (2010). . https://www.denvergov.org/opendata/dataset/city-and-county-of-denver-census-blocks-2010
Google Scholar11. Izrael, D., Hoaglin, DC., Battaglia, MP. A SAS Macro for Balancing a Weighted Sample. SAS Institute Inc; 2000. . https://support.sas.com/resources/papers/proceedings/proceedings/sugi25/25/st/25p258.pdf
Google Scholar12. National Center for Health Statistics . Vintage 2019 bridged-race postcensal population estimates. . https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#Vintage2019
Google Scholar13. US Census Bureau . County population totals: 2010-2019. 2020. . https://www.census.gov/data/tables/time-series/demo/popest/2010s-counties-total.html
Google Scholar14. Thomas, DR., Rao, JNK. Small-sample comparisons of level and power for simple goodness-of-fit statistics under cluster sampling. J Am Stat Assoc. 1987;82(398):630-636.doi:10.1080/01621459.1987.10478476
Google Scholar | Crossref15. Zou, GY., Donner, A. Construction of confidence limits about effect measures: a general approach. Stat Med. 2008;27(10):1693-1702.doi:10.1002/sim.3095 17960596
Google Scholar | Crossref | Medline16. Podewils, LJ., Burket, TL., Mettenbrink, C et al. Disproportionate incidence of COVID-19 infection, hospitalizations, and deaths among persons identifying as Hispanic or Latino—Denver, Colorado, March–October 2020. MMWR Morb Mortal Wkly Rep. 2020;69(48):1812-1816.doi:10.15585/mmwr.mm6948a3 33270613
Google Scholar | Crossref | Medline17. Council of State and Territorial Epidemiologists . Update to the standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19). 2020. . https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf
Google Scholar18. Reese, H., Iuliano, AD., Patel, NN et al. Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization—United States, February–September 2020. Clin Infect Dis. 2021;72(12):e1010-e1017.doi:10.1093/cid/ciaa1780 33237993
Google Scholar | Crossref | Medline19. Garg, S., Kim, L., Whitaker, M et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458-464.doi:10.15585/mmwr.mm6915e3 32298251
Google Scholar | Crossref | Medline20. Bajema, KL., Dahlgren, FS., Lim, TW et al. Comparison of estimated SARS-CoV-2 seroprevalence through commercial laboratory residual sera testing and a community survey (online ahead of print December 10, 2020). Clin Infect Dis.doi:10.1093/cid/ciaa1804 33300579
Google Scholar | Medline21. Centers for Disease Control and Prevention . Introduction to COVID-19 racial and ethnic health disparities. 2020. . https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/racial-ethnic-disparities/index.html
Google Scholar22. Parrott, JC., Maleki, AN., Vassor, VE et al. Prevalence of SARS-CoV-2 antibodies in New York City adults, June–October, 2020: a population-based survey. J Infect Dis. 2021;224(2):188-195.doi:10.1093/infdis/jiab296 34086923
Google Scholar | Crossref | Medline23. Hutchins, HJ., Wolff, B., Leeb, R et al. COVID-19 mitigation behaviors by age group—United States, April–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1584-1590.doi:10.15585/mmwr.mm6943e4 33119562
Google Scholar | Crossref | Medline24. Jing, Q-L., Liu, M-J., Zhang, Z-B et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(10):1141-1150.doi:10.1016/S1473-3099(20)30471-0 32562601
Google Scholar | Crossref | Medline25. Luo, L., Liu, D., Liao, X et al. Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study. Ann Intern Med. 2020;173(11):879-887.doi:10.7326/M20-2671 32790510
Google Scholar | Crossref | Medline26. Hobbs, CV., Martin, LM., Kim, SS et al. Factors associated with positive SARS-CoV-2 test results in outpatient health facilities and emergency departments among children and adolescents aged <18 years—Mississippi, September–November 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1925-1929.doi:10.15585/mmwr.mm6950e3 33332298
Google Scholar | Crossref | Medline27. Self, WH., Tenforde, MW., Stubblefield, WB et al. Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network—12 states, April–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(47):1762-1766.doi:10.15585/mmwr.mm6947a2 33237893
Google Scholar | Crossref | Medline28. Long, Q-X., Tang, X-J., Shi, Q-L et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200-1204.doi:10.1038/s41591-020-0965-6 32555424
Google Scholar | Crossref | Medline29. Spellberg, B., Nielsen, TB., Casadevall, A. Antibodies, immunity, and COVID-19. JAMA Intern Med. 2021;181(4):460-462.doi:10.1001/jamainternmed.2020.7986 33231673
Google Scholar | Crossref | Medline